Catching launch signals while they still matter

The early weeks of a pharma brand launch are full of small signals that can shape everything that follows, but they’re easy to miss or misread. The client needed a fast, clear read on how their respiratory therapy was landing: where expectations weren’t being met and what might slow uptake. The hard part was getting that insight quickly enough to actually do something with it.

We ran a rapid insight programme that captured both physician decision-making and patient experience as the launch unfolded. The team could see early gaps and misreadings as they emerged, understand what was driving them and adjust their approach without waiting for the next quarterly review.

From the first weeks of the brand launch, the client had a clear view of what was and wasn’t working, allowing them to refine messaging and positioning before small issues took hold. For example, they quickly discovered that patients were hesitating to start therapy and adjusted patient materials and physician conversations accordingly.